Navigation Links
Risperdal Lawsuit News: Pennsylvania Judge Won’t Reconsider Denial of Punitive Damages for Risperdal Gynecomastia Plaintiffs, Bernstein Liebhard LLP Reports
Date:7/22/2014

ho allegedly developed gynecomastia due to the atypical antipsychotic. All of the lawsuits assert that Johnson & Johnson and its Janssen Pharmaceuticals unit were aware of the alleged association between Risperdal and gynecomastia, but concealed this knowledge from doctors and patients. The companies are also accused of improperly promoting the off-label use of Risperdal in children long before any pediatric indications were approved in 2006.

In November 2013, Johnson & Johnson and Janssen agreed to pay $2.2 billion to resolve criminal and civil charges brought by the U.S. Department of Justice regarding the marketing of Risperdal and other drugs. According to court documents filed in the case, federal prosecutors had alleged that the companies concealed side effects associated with the medication, including an association with elevated levels of prolactin, a hormone associated with breast development and lactation. The Justice Department also accused the companies of improperly marketing Risperdal for pediatric uses. (U.S. District Court, Eastern District of Pennsylvania, 04-cv-1529)

Men and boys who allegedly developed gynecomastia due to their use of Risperdal may be entitled to file their own claim against Johnson & Johnson and Janssen. To learn more about the possible association between Risperdal and male breast growth, please visit Bernstein Liebhard LLPs website. For a free c
'/>"/>

Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. New Risperdal Lawsuit Website Published by Bernstein Liebhard LLP; Provides Side Effect Information, Litigation Updates
2. Risperdal Lawsuit News: Bernstein Liebhard LLP Notes New Report Detailing Increasing Use of Risperdal and other Antipsychotic Drugs Among Children
3. Risperdal Lawsuit News: Rottenstein Law Group LLP Comments on Plaintiffs’ Request to Unseal Key Clinical Studies Data
4. Risperdal Lawsuits Progress, as Bernstein Liebhard LLP Notes Filing of Plaintiff Brief Seeking to Unseal Risperdal Clinical Studies
5. As Risperdal Lawsuits Move Forward, Wright & Schulte LLC Learns of Bid to Keep Clinical Studies Sealed in Pennsylvania Risperdal Litigation
6. Risperdal Lawsuit News: Bernstein Liebhard LLP Notes Johnson & Johnson Bid to Keep Clinical Studies Under Seal
7. Risperdal Lawsuit News: Bernstein Liebhard LLP Comments on Federal Award to Risperdal Whistleblower
8. As Risperdal Lawsuits Move Forward, Bernstein Liebhard LLP Launches Website to Provide Information Regarding Alleged Association Between Risperdal and Gynecomastia
9. Plaintiffs in 77 Risperdal Gynecomastia Lawsuits File Motion to Force J&J to Comply with Existing Settlement Agreement, Reviewed By Wright & Schulte LLC
10. Risperdal Lawsuit News: Bernstein Liebhard LLP Comments on Release of Emails from Johnson & Johnson’s Janssen Subsidiary in Federal Risperdal Settlement
11. Risperdal Lawsuit News: Bernstein Liebhard LLP Notes Mounting Claims Involving Risperdal Gynecomastia Allegations in Pennsylvania Litigation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... Norcross, GA (PRWEB) , ... September 02, 2015 ... ... Aflac Cancer Center at Children's Healthcare of Atlanta to help support ... C.H.O.A. to discuss the upcoming WSB Radio Care-A-Thon , which is the ...
(Date:9/2/2015)... ... September 02, 2015 , ... Ericson is a noted speaker and ... HCPro and Associate Director of Education for the Association for Clinical Documentation Improvement Specialists ... for CDI Boot Camps. She serves as a CDI subject matter expert for a ...
(Date:9/2/2015)... ... September 02, 2015 , ... ... largest and fastest-growing interim clinical staffing companies, has completed a recapitalization with ... , BPOC and Heritage Group each offer extensive expertise and ...
(Date:9/2/2015)... ... September 02, 2015 , ... ... is taking action after seeing a significant increase in unlawful tactics used ... division has found many cases of OON ASCs encouraging members to have elective ...
(Date:9/2/2015)... , ... September 02, 2015 , ... Every year at ... others dread it. However, few are prepared to face the academic workload confronting them. ... Our schools haven’t prepared them since schools don’t teach students how to study. , ...
Breaking Medicine News(10 mins):Health News:DoMyOwnPestControl.com Goes Gold for Childhood Cancer Awareness Month 2Health News:ezDI Names Noted CDI Educator Cheryl Ericson as Company’s Clinical Documentation Manager 2Health News:ezDI Names Noted CDI Educator Cheryl Ericson as Company’s Clinical Documentation Manager 3Health News:ezDI Names Noted CDI Educator Cheryl Ericson as Company’s Clinical Documentation Manager 4Health News:Medical Solutions Completes Recapitalization with Beecken Petty O’Keefe & Company and Heritage Group 2Health News:Medical Solutions Completes Recapitalization with Beecken Petty O’Keefe & Company and Heritage Group 3Health News:Medical Solutions Completes Recapitalization with Beecken Petty O’Keefe & Company and Heritage Group 4Health News:TPA Cracks Down on Forbidden Tactics Used by Out-of-Network Surgical Centers 2Health News:TPA Cracks Down on Forbidden Tactics Used by Out-of-Network Surgical Centers 3Health News:5 Essential Study Tips Every Student Needs for Academic Success but Schools Do Not Teach 2Health News:5 Essential Study Tips Every Student Needs for Academic Success but Schools Do Not Teach 3
... of Queensland believe that the conotoxins present in the ... from chronic pain//. This treatment could replace the conventional ... say that the toxin, snail uses to hunt its ... effects usually caused by other pain treatments. ...
... easily available to critically ill patients. The Food and Drug ... who are extremely ill to try out experimental drugs when ... FDA has announced that they will consider the prices that ... to needy individuals .They will also clarify the norms and ...
... by researchers from University of Sydney suggested that having ... problems in breastfeeding//. The study results were published in ... ,Researchers, who studied 1,300 women who gave birth ... have the anaesthetic are more likely to have problems ...
... for the American public. A decade after genetically altered ... remain ignorant and disinclined towards them. ,According to ... and Biotechnology, the last five years have seen little ... ,Says executive director of the survey’s sponsor, Michael ...
... conducted at the Auckland Aquatic Center in Henderson. //Six 12 ... at the West Wave Aquatic Centre on Dec 10. The ... be admitted in the hospital. ,Waitakere City Council ... concerned by what had occurred and investigations are continuing into ...
... effective as popular sports drinks and gels in maintaining ... endurance athletes who participated in a study by researchers ... study results were reported as a poster presentation at ... American College of Sports Medicine in San Diego last ...
Cached Medicine News:Health News:Gene-Altered Foods -Still Not Sure 2Health News:Sports-Formulated Jelly Beans Just as Effective as Sports Drinks 2
(Date:9/2/2015)... 2015  MEI Pharma, Inc. (Nasdaq: MEIP ), ... novel therapies for cancer, today announced results for its ... - http://photos.prnewswire.com/prnh/20140805/133834 "Despite a ... pleased with how the Company is positioned entering fiscal ... President and Chief Executive Officer of MEI Pharma. "While ...
(Date:9/2/2015)... Sept. 2, 2015  Valeant Pharmaceuticals International, Inc. (NYSE: ... its affiliate has entered into a definitive agreement under ... , Inc. (NASDAQ: SURG ) for $6.50 per ... payment, Synergetics stockholders will receive additional cash payments of ... are achieved following the closing.  The transaction is expected ...
(Date:9/2/2015)... , Sept. 2, 2015 Relmada Therapeutics, ... therapies for the treatment of chronic pain, announced today ... at both the FBR Second Annual Healthcare Conference and ... follows: FBR Second Annual Healthcare Conference ... Boston No presentation, investor meetings ...
Breaking Medicine Technology:MEI Pharma Reports Fiscal Year 2015 Results 2MEI Pharma Reports Fiscal Year 2015 Results 3MEI Pharma Reports Fiscal Year 2015 Results 4MEI Pharma Reports Fiscal Year 2015 Results 5MEI Pharma Reports Fiscal Year 2015 Results 6MEI Pharma Reports Fiscal Year 2015 Results 7Valeant Pharmaceuticals To Acquire Synergetics USA 2Valeant Pharmaceuticals To Acquire Synergetics USA 3Valeant Pharmaceuticals To Acquire Synergetics USA 4Valeant Pharmaceuticals To Acquire Synergetics USA 5Relmada Therapeutics to Participate in Two Upcoming Investor Conferences 2
... Texas, Feb. 16, 2012   Lexicon Pharmaceuticals, Inc. ... on discovering breakthrough treatments for human disease, will release ... on Wednesday, February 22, 2012 before the financial markets ... webcast to discuss clinical development progress and financial results ...
... that Medicare beneficiaries are not receiving necessary medical equipment ... Congress to adopt the Market Pricing Program (MPP) ... medical equipment and services, or durable medical equipment (DME). ... Medicaid Services (CMS), which implemented the bidding program in ...
Cached Medicine Technology:Lexicon to Report Fourth Quarter and Year End 2011 Financial Results on February 22, 2012 2American Association for Homecare Calls for Market-Based Alternative to Medicare's Bidding Program; Cites Lack of Access for Beneficiaries 2American Association for Homecare Calls for Market-Based Alternative to Medicare's Bidding Program; Cites Lack of Access for Beneficiaries 3American Association for Homecare Calls for Market-Based Alternative to Medicare's Bidding Program; Cites Lack of Access for Beneficiaries 4
... Activins are polypeptide hormones which ... (TGF-) superfamily. The TGF- superfamily is ... factors which control many aspects of ... (1). Other members incude TGF-s, bone ...
... polypeptide hormones which belong to the ... TGF- superfamily is a large group ... many aspects of development, reproductive function ... incude TGF-s, bone morphogenetic proteins, growth ...
... known as bone Gla protein, is a ... a major component of the noncollagenous bone ... in bone, with a small amount produced ... [1]. During bone formation, newly synthesized osteocalcin ...
... Protein-1 (IGFBP-1) is a phosphoprotein, produced primarily ... modulates the bioactivity of IGF-I and IGF-II ... been completely defined, but the nature of ... involved in glucose regulation and IGF-mediated substrate ...
Medicine Products: